ABVC's logo.
Ticker Symbol: ABVC

ABVC BioPharma Inc

$3.42 - 21-07-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001173313

Company Profile

american brivision (holding) corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the united states. the company is developing abv-1501, a combination therapy for triple negative breast cancer; abv-1504 for major depressive disorders; abv-1505 for attention deficit hyperactivity disorder; abv-1703 for the treatment of pancreatic cancer; abv-1702 to treat myelodysplastic syndromes; and abv-1601 for treating depression in cancer patients. it has a co-development agreement with rgene corporation; collaboration agreement with biohopeking corporation to develop abv-1501; and collaborative agreement with biofirst corporation to co-develop bfc-1401 vitreous substitute for vitrectom; and license with biofirst corporation to research and develop a medical device, abv-1701 vitargus for the treatment of retinal detachment or vitreous hemorrhage. the company was founded in 2015 and is based in fremont, california. american br

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: N/A
Tags:
  • Industrial Specialties
  • Process Industries
  • Consumer Non-Durables
  • Apparel/Footwear
  • Wholesale Trade
  • Industrial Machinery and Equipment Merchant Wholesalers

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.91
Change: $0.00 ( -0.97%)
Days Range: $0.88 - $0.92
Beta: 0.20
52wk. High: $18.70
52wk. Low: $0.67
Ytd. Change -86.39%
50 Day Moving Average: $0.98
200 Day Moving Average: $4.09
Shares Outstanding: 3951388

Valuation

Market Cap: 360.0M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A